Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to -$87.8 million.

  • Apyx Medical's Retained Earnings fell 1984.09% to -$87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.8 million, marking a year-over-year decrease of 1984.09%. This contributed to the annual value of -$77.9 million for FY2024, which is 4309.25% down from last year.
  • As of Q3 2025, Apyx Medical's Retained Earnings stood at -$87.8 million, which was down 1984.09% from -$85.8 million recorded in Q2 2025.
  • Apyx Medical's Retained Earnings' 5-year high stood at -$2.3 million during Q1 2021, with a 5-year trough of -$87.8 million in Q3 2025.
  • Over the past 5 years, Apyx Medical's median Retained Earnings value was -$40.2 million (recorded in 2023), while the average stood at -$45.0 million.
  • Per our database at Business Quant, Apyx Medical's Retained Earnings crashed by 71122.81% in 2022 and then crashed by 1984.09% in 2025.
  • Apyx Medical's Retained Earnings (Quarter) stood at -$12.6 million in 2021, then plummeted by 184.72% to -$35.7 million in 2022, then plummeted by 52.37% to -$54.4 million in 2023, then plummeted by 43.09% to -$77.9 million in 2024, then fell by 12.72% to -$87.8 million in 2025.
  • Its Retained Earnings was -$87.8 million in Q3 2025, compared to -$85.8 million in Q2 2025 and -$82.1 million in Q1 2025.